Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-inflammatory Immune Environments During Canine Leishmaniosis Treatment
Canine leishmaniosis (CanL) caused by Leishmania infantum is a zoonotic disease of global concern. Antileishmanial drug therapies commonly used to treat sick dogs improve their clinical condition, although when discontinued relapses can occur. Thus, the current study aims to evaluate the effect of C...
Main Authors: | Marcos Ferreira Santos, Graça Alexandre-Pires, Maria A. Pereira, Cátia S. Marques, Joana Gomes, Jorge Correia, Ana Duarte, Lídia Gomes, Armanda V. Rodrigues, Alexandra Basso, Ana Reisinho, José Meireles, David Santos-Mateus, Maria Teresa Villa Brito, Luís Tavares, Gabriela M. Santos-Gomes, Isabel Pereira da Fonseca |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fvets.2019.00362/full |
Similar Items
-
COMPARISON OF ORAL CHLOROQUINE WITH SYSTEMIC MEGLUMINE ANTIMONIATE IN TREATMENT OF CUTANEOUS LEISHMANIASIS
by: Muhammad Farooq, et al.
Published: (2021-02-01) -
Novel methods for the encapsulation of meglumine antimoniate into liposomes
by: F. Frézard, et al.
Published: (2000-07-01) -
New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate
by: Najla Daadaa, et al.
Published: (2021-03-01) -
Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
by: Deninson Alejandro Vargas, et al.
Published: (2019-06-01) -
Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice
by: Samanta Etel Treiger Borborema, et al.
Published: (2019-03-01)